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metabolically	 active,	 offering	 a	window	 for	 assessing	 the	 viability	
of	the	graft.	Several	research	groups	have	proposed	putative	mark-
ers	of	organ	viability	 in	 this	 context,	 but	 their	 utility	 in	predicting	










into	 functional	 proteins	 whereas	 others	 upregulate	 other	 cellular	
functions.9	 Several	 studies	 have	 recently	 investigated	 the	 release	









perfusate	 and	 bile	 of	 normothermically	 perfused	 liver	 grafts	 cor-
relate	with,	and	are	predictive	of,	hepatocellular	and	cholangiocel-
















Upon	 arrival	 at	 the	 UMCG,	 NMP	 was	 performed	 using	 the	 Liver	
Assist	(Organ	Assist,	Groningen,	the	Netherlands)	with	a	perfusion	
solution	based	on	packed	 red	blood	 cells	 and	 fresh	 frozen	plasma	
as	described	previously.15	Bile	and	perfusion	fluid	samples	were	ob-
tained	at	baseline	prior	 to	 connecting	 the	 liver	 and	at	30	minutes	
intervals,	 and	 essentially	 deprived	 of	 cells	 by	 centrifugation	 for	
5	minutes	at	2700	rpm.	Supernatants	were	subsequently	stored	at	
−80°C	until	further	use.
2.3 | Assessment of hepatobiliary 
function and injury
Lactate,	 glucose,	 bicarbonate,	 and	 total	 bilirubin	 were	 measured	














2.5 | Reverse transcription and real-time 
polymerase chain reaction (qRT-PCR)
Complement	 DNA	 (cDNA)	 synthesis	 was	 performed	 using	 the	
Taqman	microRNA	Reverse	Transcription	Kit	 (Applied	Biosystems,	
Carlsbad,	CA,	USA)	 as	 suggested	by	 the	manufacturer	with	minor	
modifications	 as	 described	 previously.16	 To	 eliminate	 qRT-PCR	 in-
hibition	by	heparin,	 the	RT	reactions	were	co-incubated	with	6	 IU	
heparinase	(New	England	Biolabs).17	One	hundred	amol	of	synthetic	


















Levels	 of	 endogenous	 miRs	 in	 perfusate	 and	 bile,	 represented	 as	
relative	 values	 (2-Cq),	 were	 normalized	 using	 the	 relative	 values	 of	
the	 spiked-in	 synthetic	 Cel-miR-39	 as	 described	 by	 Vandesompele	
et	al	with	the	highest	relative	value	set	to	1.19	Continuous	variables	
were	presented	as	median	with	 interquartile	 rage	 (IQR).	 In	order	 to	





cal	 analyses	were	performed	using	SPSS	 software	 version	22.0	 for	
Windows	(SPSS,	Inc)	and	GraphPad	Prism	5.0	(GraphPad	Software).
3  | RESULTS






LDH	 in	 bile	 reflect	 hepatocyte	 and	 cholangiocyte	 injury,	 respec-
tively.	 Lactate	 in	 perfusate,	 bilirubin	 in	 bile,	 and	 (cumulative)	 bile	
production	 reflect	 hepatocyte	 function	 during	 NMP.	 Bicarbonate	
in	 bile	 and	 the	 bile	 glucose/perfusate	 glucose	 ratio	 are	 indicators	
of	 cholangiocyte	 secretory	 function	 and	 cholangiocyte	 resorptive	
function,	respectively.20
TA B L E  1  Mature	microRNA	sequences	and	assays





TA B L E  2  Donor	characteristics
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3.2 | Hepatocyte- and cholangiocyte-derived miRs 





1F	 illustrated	 the	 relative	 ratios	between	HDmiR-122	and	CDmiR-
222	in	the	respective	fluids.	Both	HDmiR-122	and	CDmiR-222	levels	













3.3 | miR levels and microscopic assessment of liver 
parenchymal injury
Often	livers,	declined	for	transplantation	on	subjective	assessment	
by	 the	 transplant	 surgeon,	 were	 shown	 to	 display	 minimal	 mor-
phological	changes	after	histological	examination.21	We	set	out	 to	
evaluate	the	histological	observations	described	earlier	22 and cor-







and	miRs	 at	 the	 start	 of	NMP	was	 observed	 (HDmiR-122	 r	 =	 .79,	
P	<	.05;	CDmiR-222	r	=	.68,	P	<	.01;	Figure	2A).	The	relative	CDmiR-





3.4 | Early miR release into perfusate is predictive of 
late hepato-cholangiocellular parameters
Peak	HDmiR-122	levels	precede	peak	serum	AST	levels	 in	predict-






r	=	 .90,	P	<	 .001;	CDmiR-222	r	=	 .78,	P	<	 .01;	Figure	3A).	A	similar	














perfusate	 glucose	 ratio	 did	 not	 show	 a	 correlation	with	 early	miR	
levels	in	perfusate	(HDmiR-122	r	=	.23,	P	=	.55;	CDmiR-222	r	=	.20,	
P	=	.61;	data	not	shown).
3.5 | CDmiR-222 release into bile is predictive of 
later hepato-cholangiocellular parameters, except for 
hepatocellular and cholangiocyte resorptive functions
The	 relative	 values	 of	 CDmiR-222	 in	 bile	 at	 2	 hours	 NMP	 corre-
lated	very	strongly	with	peak	AST	in	perfusate	and	peak	LDH	in	bile	
(r	=	 .88,	P < .001 and r	=	 .81,	P	=	 .003,	respectively;	Figure	4A-B).	
HDmiR-122	in	bile	correlated	less	strongly,	and	nearly	significantly,	












3.6 | The relative HDmiR-122/CDmiR-222 ratio in 
perfusate correlates with cumulative bile production
Cumulative	bile	production	during	NMP	has	been	considered	a	good	
parameter	 of	 liver	 function	 in	 non-transplanted	 research	 livers.15 
Therefore,	we	correlated	the	previously	mentioned	clinical	markers	
in	perfusate	and	bile,	as	well	as	the	HDmiR-122/CDmiR-222	ratio,	to	
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P	 =	 .21;	 r	 =	 −.5,	P	 =	 .10,	 respectively)	 and	bile	 (r	 =	 −.08,	P	 =	 .99;	
r =	−.42,	P	=	.20,	respectively)	(data	not	shown).	Interestingly,	cumu-
lative	bile	production	at	30	minutes	was	not	predictive	for	cumula-
tive	bile	production	5.5	hours	 later	 (r	=	 .28,	P	=	 .38)	 (not	 shown).	







grafts.	 This	 is	 the	 first	 study	 to	 report	 on	miRs	 at	 different	 time	
points	during	NMP	of	human	donor	livers.
Overall,	 the	 current	 study	 showed	 that	 poor	 quality	 liver	 grafts	





























tation of the entire liver compared to miR levels measured in total 
RNA	samples	from	biopsies.11	Furthermore,	miRs	have	been	shown	
to	be	earlier	and	more	sensitive	markers	of	liver	damage	than	more	
conventional	markers	 such	 as	AST	or	ALT,	 and	machine	perfusion	
potentially	 allows	 for	 an	 even	 more	 representative	 and	 dynamic	
evaluation of the liver graft.16,25,26	 In	 addition,	machine	 perfusion	





or as a therapeutic target itself.31
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Studies	have	shown	that	HDmiR-122	levels	in	graft	preservation	
fluid	are	higher	in	DCD	grafts	and	in	livers	that	went	on	to	develop	
EAD	 and	NAS.11,12,14	 Higher	HDmiR-122	 levels	 in	 perfusate	were	
also	measured	in	a	porcine	DCD	NMP	model	with	increasing	warm	




positively	 correlated	with	 hepatocellular	 injury	 during	NMP	 is	 en-
tirely	in	line	with	the	currently	available	literature.






















was	 shown	 to	 be	 abundantly	 expressed	 in	 biliary	 epithelium.14,35 
Elevated	levels	have	been	reported	in	serum	of	patients	with	primary	













function.	 These	 results	 are	 in	 concordance	 with	 a	 previous	 study	





Subsequently,	 we	 observed	 that	 the	 HDmiR-122/CDmiR-222	
ratio	correlated	with	cumulative	bile	production	during	NMP,	with	
significantly	higher	ratios	 in	 livers	with	better	bile	production.	The	
relative	 ratio	 of	 hepatocyte-derived	 and	 cholangiocyte-derived	
miRs	represents	a	relative	degree	of	hepatocellular	 injury	using	an	
internal	stabilization	factor.	Elevated	HDmiR-122/CDmiR-222	ratios	










however,	 showed	 that	 the	use	of	NMP	 for	 viability	 assessment	of	
otherwise	 discarded	 grafts	 was	 clinically	 feasible	 13,22,39 and also 
helped to define optimal criteria for the final acceptance of these 
rejected	grafts	once	 their	viability	had	been	 re-assessed.22,40 As a 
consequence,	 the	 clinical	 parameters	 for	 hepato-cholangiocellular	
injury	and	function	were	used	as	mere	viability	markers	to	correlate	
with	 relative	miR	values.15,22,24 Mergental et al proposed compos-
ite	viability	criteria	based	on	analysis	of	12	discarded	human	livers.	
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Multilevel	 statistical	 analysis	 showed	 that	 lactate	 clearance	 strati-
fied	his	cohort	 in	2	distinct	groups	with	pH	and	bile	production	as	
discriminative parameters.22	 It	 should,	 however,	 be	 noted	 that	 in	
studies	where	 livers	were	 transplanted	 after	NMP,	 these	 parame-
ters	 tend	to	vary	extensively	and	are	not	predictive	 for	 transplant	
outcome	after	NMP	alone.8,21 As lactate levels for the transplanted 





was	 observed,	 nor	with	 the	 other	 viability	 criteria	 components.	 It	
should	be	noted,	however	that,	as	far	as	lactate	is	concerned,	2	hours	
of	NMP	are	sufficient	to	assess	viability.	For	pH,	to	determine	sta-
bility,	 longer	periods	of	NMP	are	 required	as	 the	 first	2	hours	are	
already	needed	 to	 reach	a	plateau.	At	present,	 a	6-hour	period	of	
NMP,	either	with	or	without	additional	perfusion	treatments,	is	still	
considered	 the	 standard.	 Another	 limitation	 is	 the	 relatively	 small	
number	of	liver	grafts	included	in	this	study	due	to	a	minimal	avail-
ability	of	research	livers.	To	avoid	further	stratification	and	reduced	
numbers,	both	DCD	and	DBD	 livers	were	 included.	Despite	 these	
small	numbers	and	graft	type	heterogeneity,	there	were	still	signif-
icant	differences	observed	 in	miR	detection	 in	perfusate	 and	bile,	
which	supports	the	utility	of	relative	miR	values	to	serve	as	poten-
tial,	 dynamic,	 biomarkers.	 Lastly,	 the	measurement	of	miRs	 is	 cur-
rently	a	time-consuming	process,	as	it	takes	4-5	hours	to	complete	
the	analysis,	 although	 techniques	are	under	development	 to	make	
clinical	applications	possible.41	Nonetheless,	the	predictive	proper-
ties	of	these	miRs	might	aid	in	the	detection	of	transplantable	livers	
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